US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 34.720
  • +3.280+10.43%
Close May 31 16:00 ET
  • 34.720
  • 0.0000.00%
Post 19:08 ET
617.88MMarket Cap-619P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-1.65%5.84M
-76.53%26M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
30.21%110.78M
-43.90%16.8M
-15.22%20.71M
99.73%39.27M
Operating revenue
-1.65%5.84M
-76.53%26M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
30.21%110.78M
-43.90%16.8M
-15.22%20.71M
99.73%39.27M
Cost of revenue
Gross profit
Operating expense
-21.10%19.19M
16.81%112.42M
76.34%44.6M
-12.07%19.62M
-6.00%23.89M
4.71%24.32M
7.32%96.24M
-2.20%25.29M
-15.48%22.31M
32.28%25.41M
Selling and administrative expenses
65.94%9.45M
70.07%40.58M
250.52%22.17M
14.63%6.61M
-2.02%6.11M
2.85%5.7M
13.97%23.86M
14.13%6.32M
5.97%5.77M
31.23%6.23M
-General and administrative expense
65.94%9.45M
70.07%40.58M
250.52%22.17M
14.63%6.61M
-2.02%6.11M
2.85%5.7M
13.97%23.86M
14.13%6.32M
5.97%5.77M
31.23%6.23M
Research and development costs
-47.71%9.74M
-0.74%71.84M
18.26%22.43M
-21.39%13M
-7.30%17.78M
5.29%18.62M
5.30%72.38M
-6.65%18.97M
-21.06%16.54M
32.63%19.18M
Operating profit
27.38%-13.35M
-694.41%-86.42M
-327.64%-36.33M
-717.07%-13.07M
-234.47%-18.64M
-270.62%-18.38M
416.25%14.54M
-308.34%-8.5M
18.79%-1.6M
2,966.37%13.86M
Net non-operating interest income expense
0
6.53%-2.83M
0
-58.73%-1.27M
-5.17%-752K
-14.29%-808K
-6.58%-3.03M
-13.50%-807K
-12.80%-802K
-0.56%-715K
Non-operating interest expense
--0
-6.53%2.83M
--0
58.73%1.27M
5.17%752K
14.29%808K
6.58%3.03M
13.50%807K
12.80%802K
0.56%715K
Other net income (expense)
-1,657.32%-43.48M
-742.48%-149.46M
-1,175.44%-160.33M
191.79%5.34M
276.12%8M
-113.22%-2.47M
1,120.31%23.26M
65.46%14.91M
-1,046.74%-5.81M
-194.20%-4.54M
Gain on sale of security
-71.64%-4.68M
-674.94%-131.85M
-1,063.58%-141.96M
187.43%5.08M
270.73%7.76M
-114.71%-2.73M
1,099.26%22.93M
63.52%14.73M
-1,060.99%-5.81M
-194.31%-4.54M
Special income (charges)
---39.3M
---18.3M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--39.3M
--18.3M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
99.22%508K
109.39%691K
-135.43%-62K
25,200.00%253K
--245K
65.58%255K
2,100.00%330K
--175K
-88.89%1K
----
Income before tax
-162.31%-56.82M
-786.54%-238.71M
-3,608.62%-196.66M
-9.59%-9M
-232.39%-11.39M
-175.28%-21.66M
457.68%34.77M
-54.71%5.61M
-297.58%-8.21M
88.41%8.6M
Income tax
-3,019.87%-19M
-6,497.22%-19M
0
-103.81%-609K
-308.70%-288K
-102.03%-321K
Net income
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
88.41%8.6M
Net income continuous Operations
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
88.41%8.6M
Minority interest income
Net income attributable to the parent company
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
88.41%8.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
88.41%8.6M
Basic earnings per share
-147.64%-10.5
-791.67%-49.8
-4,733.33%-41.7
-20.00%-1.8
-216.67%-2.1
-161.45%-4.24
209.09%7.2
-70.00%0.9
68.75%-1.5
50.00%1.8
Diluted earnings per share
-147.64%-10.5
-1,760.00%-49.8
-2,680.00%-41.7
-20.00%-1.8
-216.67%-2.1
-276.67%-4.24
145.45%3
-266.67%-1.5
68.75%-1.5
2,951.26%1.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -1.65%5.84M-76.53%26M-50.78%8.27M-68.37%6.55M-86.63%5.25M-82.53%5.94M30.21%110.78M-43.90%16.8M-15.22%20.71M99.73%39.27M
Operating revenue -1.65%5.84M-76.53%26M-50.78%8.27M-68.37%6.55M-86.63%5.25M-82.53%5.94M30.21%110.78M-43.90%16.8M-15.22%20.71M99.73%39.27M
Cost of revenue
Gross profit
Operating expense -21.10%19.19M16.81%112.42M76.34%44.6M-12.07%19.62M-6.00%23.89M4.71%24.32M7.32%96.24M-2.20%25.29M-15.48%22.31M32.28%25.41M
Selling and administrative expenses 65.94%9.45M70.07%40.58M250.52%22.17M14.63%6.61M-2.02%6.11M2.85%5.7M13.97%23.86M14.13%6.32M5.97%5.77M31.23%6.23M
-General and administrative expense 65.94%9.45M70.07%40.58M250.52%22.17M14.63%6.61M-2.02%6.11M2.85%5.7M13.97%23.86M14.13%6.32M5.97%5.77M31.23%6.23M
Research and development costs -47.71%9.74M-0.74%71.84M18.26%22.43M-21.39%13M-7.30%17.78M5.29%18.62M5.30%72.38M-6.65%18.97M-21.06%16.54M32.63%19.18M
Operating profit 27.38%-13.35M-694.41%-86.42M-327.64%-36.33M-717.07%-13.07M-234.47%-18.64M-270.62%-18.38M416.25%14.54M-308.34%-8.5M18.79%-1.6M2,966.37%13.86M
Net non-operating interest income expense 06.53%-2.83M0-58.73%-1.27M-5.17%-752K-14.29%-808K-6.58%-3.03M-13.50%-807K-12.80%-802K-0.56%-715K
Non-operating interest expense --0-6.53%2.83M--058.73%1.27M5.17%752K14.29%808K6.58%3.03M13.50%807K12.80%802K0.56%715K
Other net income (expense) -1,657.32%-43.48M-742.48%-149.46M-1,175.44%-160.33M191.79%5.34M276.12%8M-113.22%-2.47M1,120.31%23.26M65.46%14.91M-1,046.74%-5.81M-194.20%-4.54M
Gain on sale of security -71.64%-4.68M-674.94%-131.85M-1,063.58%-141.96M187.43%5.08M270.73%7.76M-114.71%-2.73M1,099.26%22.93M63.52%14.73M-1,060.99%-5.81M-194.31%-4.54M
Special income (charges) ---39.3M---18.3M--------------0--0------------
-Less：Restructuring and merger&acquisition --39.3M--18.3M--------------0--0------------
Other non- operating income (expenses) 99.22%508K109.39%691K-135.43%-62K25,200.00%253K--245K65.58%255K2,100.00%330K--175K-88.89%1K----
Income before tax -162.31%-56.82M-786.54%-238.71M-3,608.62%-196.66M-9.59%-9M-232.39%-11.39M-175.28%-21.66M457.68%34.77M-54.71%5.61M-297.58%-8.21M88.41%8.6M
Income tax -3,019.87%-19M-6,497.22%-19M0-103.81%-609K-308.70%-288K-102.03%-321K
Net income -162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M88.41%8.6M
Net income continuous Operations -162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M88.41%8.6M
Minority interest income
Net income attributable to the parent company -162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M88.41%8.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M88.41%8.6M
Basic earnings per share -147.64%-10.5-791.67%-49.8-4,733.33%-41.7-20.00%-1.8-216.67%-2.1-161.45%-4.24209.09%7.2-70.00%0.968.75%-1.550.00%1.8
Diluted earnings per share -147.64%-10.5-1,760.00%-49.8-2,680.00%-41.7-20.00%-1.8-216.67%-2.1-276.67%-4.24145.45%3-266.67%-1.568.75%-1.52,951.26%1.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg